Pharmacies Books

For questions, comments or corrections you can contact the editor at

ScottLTraub@att.net

PS. In order to update address, I was was forced to give the book a Star rating.

this was a very helpful book for me throughout medical school. it explored all aspects of everything we covered in classes, plus other intresting subjects. i could refer to it whenever i had questions on lab tests, and the answers were always there. Scott Traub's "Basic Skills in Interpreting Laboratory Data" is i must buy for any medical school student. :)

I am very pleased with this order. Very much to my surprise, I received it in less than a week and it was delivered just as it was advertised, new and in shrinkwrap. I would recommend this seller to anybody.

When I received the book,I just tried to review in order to express thanks.But I couldn't know how to operate.I tried several times and eventually gave up.

I think all the services are wonderful as it promised.

Thanks again.

I am a pharmacist at a large hospital in TN and find this book is indispensible. It is very easy to find information and lists accepted usage not just info from a package insert.

I have been a chemotherapy nurse for years, and find Davis's Guide to IV medications to be an excellent resource book. Compatibilities as well as incompatibilites with other drugs are listed, as well as patient teaching, lab considerations, side effects and much more valuable information. This is the only IV drug reference you will need.

I work in one of the biggest pharmaceutical companies, in the marketing-e-business department. I can assure you that this is by far the best book about the pharmaceutical industry. It is not only about Information systems related areas, it covers too marketing, R&D, Human resources, finance, sales, etc. It has a great vision about the industry; I can tell you that book is "the bible" in our corporate headquarters. If you want to increase your knowledge about marketing in the industry, this is the book for you. The author is Editor of a leading journal, the "International Journal of Medical Marketing", teacher at INSEAD and a consultant for Pfizer, Merck, GSK, Aventis, Novartis and Roche, so he includes in this book information from top sources.

A "digital strategy in the pharmaceutical industry" is not at all the addition of an "e-business"-unit or -department to an existing organisational structure. It's much more about how sales & marketing, research & development and other functions can increase efficiency and effectiveness by making use of digital technology. At the same time, the technological challenges suggest to develop an integrated strategic approach instead of focusing on sales & marketing or other functions alone or in isolation. This book tells you why. And - to a certain degree - also how. Since few readers will be competent in all covered business functions, it is very helpful that the authors provide definitions and basic background information for all of them, before they outline the impact of digital technology and strategy. Finally, a great amount of examples from real business cases illustrate the theoretical framework.
To me this book is a very successful approach to present an integrated view of different business functions and IT in the pharmaceutical industry.

As a first year nursing student, med-math is one of the tasks I had to accomplish. This book explains it in easy to read terms. A must for every nursing student!

For any person going into a pharmacy-related field, I would highly recommend this book. My greated challenge has been dosage calculations, and this book has been an excellent resourse.

This book is a pharmacist's bible; but a bit difficult for most people to understand how to navigate; once you can navigate it, it is indispensible. Great book.

This drug book is more helpful than any other because it groups meds into classes and compares them. It's the book you go to when you really want to get the full scoop on a medicine or how to prescribe the medicine.

A very well written walk through of basic knowledge into dose-response data and synergistic relationships. I found it very helpful.

The statistical analysis of drug combination data in the literature is of a generally poor quality. This is not through lack of guidance in the literature, but rather because the relevant papers are scattered throughout the statistical and pharmacological literature, making it difficult for researchers to get a good overview of available methodology. What is needed is a single work where the required information is brought together. This book is it! The book covers most of the statistical methods required for drug combination studies, from designing the study to optimise power, fitting dose-response curves, to analysing the data. Many examples are given, which the reader can work through to confirm their understanding. The presentation is very clear, so even those with a limited knowledge of statistics should be able to follow it. The book does not aim to cover all of the available methods for analysing drug combination data, but the methods it does contain will be adequate in most cases. To balance my review I should point out the weak aspects of the book. It is not easy to find any. But maybe some of the material could have been omitted - for example formulas for calculating a linear regression and the variances of the estimates, which most researchers would just want to get from a computer output. Also, there are over 30 pages of tables, such as logarithms, probits, t-tables etc, which most researchers would have access to from other books, and which are rarely required as software normally does all the work. Besides, there is some strange formatting in Table A-2 (natural logarithms). For example, ln(0.1) is given as "7.6974-10"; why not just -2.3026? These criticisms are trivial in relation to the positive aspects. Any researcher studying drug combinations for synergistic or antagonistic effects will need this book. I like it.

"The United States Pharmacopeia (USP) contains over 14,000 drugs, each of which is a specific chemical compound with a biological activity that is medically useful. Most of these drugs have been developed commercially by the international pharmaceutical industry and, as a consequence, are associated with one or more trade names. Several names are frequently assigned to drugs, mainly for marketing purposes. Drugs are often manufactured and sold under license agreements with the original developer and they acquire new names. In addition to these trivial names that may be associated with a drug, it may have several chemical names, developed according to various rules of nomenclature, which allow precise identification of the chemical entity involved. The consumer or researcher seeking information often has only on trivial name, on used (for example) in an advertisement, and this name contains no information on the composition or use of the drug. The chemical name is essential to the scientist, but this gives no hint as to the trade names(s) or general use of the drug.

Some 10,000 representative drugs in common use are described in Part I of this book. Every drug has been given an entry name, and within each drug category, entries are arranged alphabetically by that name. The entry name is the one most commonly used for the chemical entity and is usually the U.S. adopted name: the one under which the drug is listed in the USP. The book is organized into 201 therapeutic categories, which each category presented in alphabetical order. Drugs that have distinct activities, for example an antiarrhythmic agent with coronary vasodilator properties, are found in the appropriate sections. Thus, there is some duplication throughout Part I. However, this organization permits the reader to determine, at a glance, the number of drugs available, as well as the different chemical families which may be represented within a specific therapeutic category. For example, this database lists 483 penicillin-based antibiotics, 318 antihypertensives, 135 tranquilizers, and 68 drugs used to mange Parkinson's disease. The increasing sophistication of pharmaceutical research may also be discerned by noting the populations in such categories as ACE inhibitors (40 drugs) and histamine H2 receptor agonists (18 drugs).

Within each record the subject drug is associated with its Chemical Abstracts Service (CAS) registry number (also listed numerically in Part II, Index 1). Each record also provides, as available, two other numeric identifiers for the chemical: the monograph number from the 12th edition of The Merck Index and the European Inventory of Existing Commercial Chemical Substances (EINECS) number (also listed in Part II, Index 2). The chemical name, molecular formula (but not the chemical structure), and a list of trade names and synonyms are provided; the physical properties of each compound are described, and the known therapeutic utility and in some cases acute toxicity data re recorded in the main entries in Part I. Part III lists the manufacturers and suppliers of the drugs.

This comprehensive coverage of 10,000 drugs currently in use will be a valuable source of information to research chemists, pharmaceutical researchers, physicians and drug information centers, and others who have a need to quickly to find basic information on a particular drug for which information sources are obscure. This volume, edited by a well-know and respected authority in the field of chemical information and computational chemistry, is highly recommended for all libraries involved with drugs . . ." Journal of Medicinal Chemistry, John L. Neumeyer, Harvard Medical School

"A bevy of drug dictionaries are competing for attention; see, e.g., Concise Dictionary of Pharmacological Agents: Properties and Synonyms (CH, Jul'00). With 10,000 entries, Drugs takes the middle ground between Concise Dictionary and Merck Index (more than 4,000 entries; 1889-) and multivolume encyclopedias. Outstanding attributes of Drugs's entries are its inclusion of trade names, chemical names, generic names, CAS registry numbers, Merck Index entry numbers when available, and European Inventory of Existing Commercial Chemical Substances (EINECS) numbers. Drugs are grouped by therapeutic category; when a drug has multiple indications, it is listed in several groups. The wealth of physical property data supplied rivals Merck Index-melting and boiling points, density, LTV spectra, optical rotation, toxicity data-but unlike Merck, no references to patents or scientific literature are given. Molecular formulas are given but no structure drawings. A distinct asset is the inclusion of manufacturer and supplier information. There are four indexes: CAS Registry Number, EINECS number, names and synonyms including investigational numbers and chemical names, and therapeutic category. The "Directory of Manufactures and Suppliers" complements the usual street and telephone listings with URLs. An outstanding reference for medical and science libraries, especially those serving researchers. "Choice Magazine J. S. Whelan,Massachusetts College of Pharmacy and Health Sciences

Chow has done an excellent job of collecting articles from the leading researchers in the pharmaceutical and biologics industry including FDA employees. The terms are specialized but important to those industries. The articles are scholarly and informative. The quality is similar to those in the Encyclopedia of Statistical Science. Most of the terms are also of interest to statisticians like myself who work in the medical device industry. A sample of the items are "Adjustment for Covariates", "Bayesian Statistics", "Bioassay", "Clinical Trials", "Equivalence Trials", "Food and Drug Administration", "Intention-to-Treat Analyses", "International Conference on Harmonization", "Multiple Comparisons", "Postmarketing Surveillance", "Sample Size Determination", and "Surrogate Endpoint".
This is a particularly good reference for statisticians who work on clinical trials regulated by the FDA. However keep in mind that it is very specialized and is rather expensive.

Chow has done an excellent job of collecting articles from the leading researchers in the pharmaceutical and biologics industry including FDA employees. The terms are specialized but important to those industries. The articles are scholarly and informative. The quality is similar to those in the Encyclopedia of Statistical Science. Most of the terms are also of interest to statisticians like myself who work in the medical device industry. A sample of the items are "Adjustment for Covariates", "Bayesian Statistics", "Boassay", "Clinical Trials", "Equivalence Trials", "Food and Drug Administration", "Intention-to-Treat Analyses", "International Conference on Harmonization", "Multiple Comparisons", "Postmarketing Surveillance", "Sample Size Determination", and "Surrogate Endpoint".

This is a particularly good reference for statisticians who work on clinical trials regulated by the FDA. However keep in mind that it is very specialized and is rather expensive.

Finally, an herbal reference book that combines both traditional uses with current scientific research in an easy to read format! This book just keeps on giving information: in the back appendixes are recommended reading lists, periodicals, library resources, internet resources, herb organizations and associations, and herb education programs! Again, I say WOW!

This is a well-rounded book that contains information on historical/traditional uses as well as current research, international acceptance, and safety information. It's five- star rating system gives you an at-a-glance overview of each herb. Each chapter is on a single herb, and the index makes it very easy to look up a health condition or topic of interest quickly. If you think you already have too many herbal books, you haven't seen this one yet!